StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

(S)-3-[3-(tert-Butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazolmonomaleat

Timolol Maleate

HCID 5281056
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
26921-17-5
Standard-SMILES
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O
InChIKey
WLRMANUAADYWEA-NWASOUNVSA-N
Summenformel
C17H28N4O7S
Durchschnittliche Molmasse
432,5 g/mol
Monoisotopische Masse
432,16787042

Überblick

(S)-timolol maleate is the maleic acid salt of the active (S)-enantiomer of timolol, comprising equimolar amounts of (S)-timolol and maleic acid. It has a role as a beta-adrenergic antagonist, an antihypertensive agent, an anti-arrhythmia drug and an antiglaucoma drug. It contains a (S)-timolol (anhydrous).

Namen und Bezeichner

Bevorzugter Name
Timolol Maleate
IUPAC
(Z)-but-2-enedioic acid;(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Lokaler Name
(S)-3-[3-(tert-Butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazolmonomaleat
Englischer Name
(S)-Timolol maleate
Summenformel
C17H28N4O7S
Molmasse
432.49

Namen und Synonyme

Timolol maleate26921-17-5IstalolTimoptic-XEOphtamololTimoptic in OcudoseAquanilTimololi maleasTimolol (as maleate)Timolol hydrogen maleate saltTimolol maleate, s-enantiomerwp-934
Weitere Namen anzeigen
TimoLTimolol maleate CRStimopticTIMOLOL MALEATE USPTIMOLOL MALEATE SALT2-Propanol, 1-(1,1-dimethylethyl)amino-3-4-(4-morpholinyl)-1,2,5-thiadiazol-3-yloxy-, (2S)-, (2Z)-2-butenedioate (1:1) (salt)mk950Betimbetime
P8Y54F701RNSC-757351CHEBI:9600(-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate (1:1) (salt)2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-, (Z)-2-butenedioate (1:1) (salt)DUOTRAV COMPONENT TIMOLOL MALEATEGANFORT COMPONENT TIMOLOL MALEATEXALACOM COMPONENT TIMOLOL MALEATE

Datenbank-Bezeichner

CAS
26921-17-5、50929-98-1、60469-65-0
PubChem CID
5281056
DTXSID
DTXSID3047504
ChEMBL
CHEMBL1200870
ChEBI
CHEBI:9600
UNII
P8Y54F701R
EC Number
248-111-5、256-854-1、262-251-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
183 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
12
Frei drehbare Bindungen
9
Schwere Atome
29
Formalladung
0
Komplexität
429

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Adrenergic Beta-Antagonists; Antiarrhythmics; Antiglaucoma Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section174.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
202 · 202-203 °C(lit.)
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: soluble
Aggregatzustand
powder
pka
9.2 · 9.2
Farbe
white to off-white
Wasserlöslichkeit
2 O: · H2O: solubleethanol: soluble
Merck
14 · 14,9444
InChIKey
WLRMANUAADYWEA-NWASOUNVSA-N
SMILES
C1(=NSN=C1OC[C@@H](O)CNC(C)(C)C)N1CCOCC1.C(/C(=O)O)=C/C(=O)O |&1:7,r|
CAS Datenbank
26921 · 26921-17-5(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 1.1% (1 of 89) of reports.

Danger

H302 (98.9%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P270, P280, P301+P317, P318, P319, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 89 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationTimolol maleate: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (S)-, (Z)-2-butenedioate (1:1) (salt): Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (98.9%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Timolol maleate

Ambiguous-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
3
hs_code
29349990
RTECS-Nr.
UA8475000
risk_code
22-63-36/37/38
hazard_code
Xn,Xi
safety_code
36-37/39-26
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 OralRepr. 2

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 6 Einträge

TIMOLOL MALEATE

beta-Adrenergic Blocker [EPC]; Adrenergic beta-Antagonists [MoA]

TIMOLOL MALEATE OPHTHALMIC

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

TIMOLOL MALEATE OPHTHALMIC GEL FORMING

beta-Adrenergic Blocker [EPC]; Adrenergic beta-Antagonists [MoA]

MeSH Pharmacological Classification · 3 Einträge

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Anwendungen · 2 Einträge

BeschreibungTimolol is a non-selective β-adrenergic receptor antagonist with log Kd values of -8.27, -9.86, and -6.8 for binding to human β1-, β2-, and β3-adrenoceptors, respectively. It has been reported that only the (S) enantiomer contributes to the β-blocking effects of racemic timolol, but the weakly active (R) isomer maintains a beneficial effect on intraocular pressure without the undesirable side-effect of bronchial constriction caused by non-selective action of (S)-timolol on β1 and β2 receptors. Timolol has been use alone and in fixed combinations with either prostaglandin analogs or carbonic anhydrase inhibitors to reduce intraocular pressure in research models of ocular hypertension and glaucoma.

Verwendenbetaadrenergic blocker

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2-Methyl-2-propanaminTosylchloridNatriumtetrahydroboratMaleinsäure

Ergänzende Hinweise

DefinitionChEBI: The maleic acid salt of the active (S)-enantiomer of timolol, comprising equimolar amounts of (S)-timolol and maleic acid.

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1603402
HRID 1603402als Produkt
Reaktionsgleichung von HRID 1709982
HRID 1709982als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung